REVELATION BIOSCIENCES, INC. Prepaid Expense and Other Assets, Current
REVELATION BIOSCIENCES, INC. (REVB) had Prepaid Expense and Other Assets, Current of $201.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $201.72K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $92.62K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $111.30K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $123.93K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $201.72K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $92.62K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $111.30K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $123.93K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $186.05K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $223.27K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $66.70K 10-K · filed 2026-02-26 |
| 2024-09-30 | $117.85K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $125.74K 10-Q/A · filed 2024-09-23 |
| 2024-03-31 | $71.88K 10-Q/A · filed 2024-09-23 |
| 2023-12-31 | $84.69K 10-K · filed 2025-03-06 |
| 2023-09-30 | $152.64K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $250.01K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $332.39K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $73.13K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $309.63K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $575.48K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $684.78K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $637.34K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |